Logo image of VCEL

VERICEL CORP (VCEL) Stock Fundamental Analysis

USA - NASDAQ:VCEL - US92346J1088 - Common Stock

36.43 USD
-0.02 (-0.05%)
Last: 10/22/2025, 8:07:08 PM
36.43 USD
0 (0%)
After Hours: 10/22/2025, 8:07:08 PM
Fundamental Rating

6

Taking everything into account, VCEL scores 6 out of 10 in our fundamental rating. VCEL was compared to 534 industry peers in the Biotechnology industry. While VCEL has a great profitability rating, there are some minor concerns on its financial health. VCEL is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make VCEL suitable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

VCEL had positive earnings in the past year.
In the past year VCEL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: VCEL reported negative net income in multiple years.
In the past 5 years VCEL always reported a positive cash flow from operatings.
VCEL Yearly Net Income VS EBIT VS OCF VS FCFVCEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.63%, VCEL belongs to the top of the industry, outperforming 90.07% of the companies in the same industry.
VCEL has a Return On Equity of 2.32%. This is amongst the best in the industry. VCEL outperforms 91.39% of its industry peers.
VCEL has a Return On Invested Capital of 0.24%. This is amongst the best in the industry. VCEL outperforms 89.89% of its industry peers.
Industry RankSector Rank
ROA 1.63%
ROE 2.32%
ROIC 0.24%
ROA(3y)-1.54%
ROA(5y)-1.26%
ROE(3y)-2.18%
ROE(5y)-1.76%
ROIC(3y)N/A
ROIC(5y)N/A
VCEL Yearly ROA, ROE, ROICVCEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

VCEL's Profit Margin of 2.85% is amongst the best of the industry. VCEL outperforms 90.45% of its industry peers.
Looking at the Operating Margin, with a value of 0.48%, VCEL belongs to the top of the industry, outperforming 89.89% of the companies in the same industry.
VCEL's Gross Margin of 73.47% is amongst the best of the industry. VCEL outperforms 82.96% of its industry peers.
VCEL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.48%
PM (TTM) 2.85%
GM 73.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y1.27%
VCEL Yearly Profit, Operating, Gross MarginsVCEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VCEL is destroying value.
The number of shares outstanding for VCEL has been increased compared to 1 year ago.
Compared to 5 years ago, VCEL has more shares outstanding
VCEL has a worse debt/assets ratio than last year.
VCEL Yearly Shares OutstandingVCEL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
VCEL Yearly Total Debt VS Total AssetsVCEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 8.29 indicates that VCEL is not in any danger for bankruptcy at the moment.
VCEL's Altman-Z score of 8.29 is amongst the best of the industry. VCEL outperforms 80.71% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that VCEL is not too dependend on debt financing.
VCEL's Debt to Equity ratio of 0.01 is in line compared to the rest of the industry. VCEL outperforms 46.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 8.29
ROIC/WACC0.03
WACC9.34%
VCEL Yearly LT Debt VS Equity VS FCFVCEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 4.97 indicates that VCEL has no problem at all paying its short term obligations.
VCEL has a Current ratio (4.97) which is in line with its industry peers.
A Quick Ratio of 4.56 indicates that VCEL has no problem at all paying its short term obligations.
VCEL has a Quick ratio of 4.56. This is comparable to the rest of the industry: VCEL outperforms 51.87% of its industry peers.
Industry RankSector Rank
Current Ratio 4.97
Quick Ratio 4.56
VCEL Yearly Current Assets VS Current LiabilitesVCEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 864691128455134976.00% over the past year.
VCEL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.71% yearly.
VCEL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.13%.
VCEL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.01% yearly.
EPS 1Y (TTM)864691128455134800%
EPS 3YN/A
EPS 5Y3.71%
EPS Q2Q%90%
Revenue 1Y (TTM)16.13%
Revenue growth 3Y14.95%
Revenue growth 5Y15.01%
Sales Q2Q%20.09%

3.2 Future

Based on estimates for the next years, VCEL will show a very strong growth in Earnings Per Share. The EPS will grow by 49.77% on average per year.
VCEL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.42% yearly.
EPS Next Y24.67%
EPS Next 2Y87.87%
EPS Next 3Y80.79%
EPS Next 5Y49.77%
Revenue Next Year15.49%
Revenue Next 2Y18.83%
Revenue Next 3Y20.01%
Revenue Next 5Y22.42%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VCEL Yearly Revenue VS EstimatesVCEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M 1B
VCEL Yearly EPS VS EstimatesVCEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 303.58 indicates a quite expensive valuation of VCEL.
90.26% of the companies in the same industry are more expensive than VCEL, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.57, VCEL is valued quite expensively.
A Price/Forward Earnings ratio of 57.34 indicates a quite expensive valuation of VCEL.
Based on the Price/Forward Earnings ratio, VCEL is valued cheaply inside the industry as 88.76% of the companies are valued more expensively.
VCEL is valuated expensively when we compare the Price/Forward Earnings ratio to 23.09, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 303.58
Fwd PE 57.34
VCEL Price Earnings VS Forward Price EarningsVCEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VCEL is valued cheaper than 89.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 177.41
VCEL Per share dataVCEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
VCEL has a very decent profitability rating, which may justify a higher PE ratio.
VCEL's earnings are expected to grow with 80.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)12.31
PEG (5Y)81.75
EPS Next 2Y87.87%
EPS Next 3Y80.79%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VCEL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VERICEL CORP

NASDAQ:VCEL (10/22/2025, 8:07:08 PM)

After market: 36.43 0 (0%)

36.43

-0.02 (-0.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners111.28%
Inst Owner Change-0.02%
Ins Owners1.04%
Ins Owner Change2.32%
Market Cap1.84B
Revenue(TTM)249.12M
Net Income(TTM)7.11M
Analysts84.29
Price Target55.42 (52.13%)
Short Float %9.51%
Short Ratio6.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.99%
Min EPS beat(2)-78.61%
Max EPS beat(2)68.63%
EPS beat(4)3
Avg EPS beat(4)16.25%
Min EPS beat(4)-78.61%
Max EPS beat(4)68.63%
EPS beat(8)6
Avg EPS beat(8)20.38%
EPS beat(12)8
Avg EPS beat(12)32.28%
EPS beat(16)8
Avg EPS beat(16)-1.68%
Revenue beat(2)0
Avg Revenue beat(2)-4.04%
Min Revenue beat(2)-4.23%
Max Revenue beat(2)-3.86%
Revenue beat(4)1
Avg Revenue beat(4)-2.16%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)2.84%
Revenue beat(8)2
Avg Revenue beat(8)-1.28%
Revenue beat(12)4
Avg Revenue beat(12)-0.41%
Revenue beat(16)5
Avg Revenue beat(16)-1.44%
PT rev (1m)2.52%
PT rev (3m)-7.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-112.19%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.8%
Valuation
Industry RankSector Rank
PE 303.58
Fwd PE 57.34
P/S 7.38
P/FCF N/A
P/OCF 38.91
P/B 5.99
P/tB 6.11
EV/EBITDA 177.41
EPS(TTM)0.12
EY0.33%
EPS(NY)0.64
Fwd EY1.74%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)0.94
OCFY2.57%
SpS4.94
BVpS6.08
TBVpS5.96
PEG (NY)12.31
PEG (5Y)81.75
Graham Number4.05
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 2.32%
ROCE 0.3%
ROIC 0.24%
ROICexc 0.34%
ROICexgc 0.35%
OM 0.48%
PM (TTM) 2.85%
GM 73.47%
FCFM N/A
ROA(3y)-1.54%
ROA(5y)-1.26%
ROE(3y)-2.18%
ROE(5y)-1.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y1.27%
F-Score7
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.17
Cap/Depr 667.96%
Cap/Sales 22.3%
Interest Coverage 250
Cash Conversion 496.85%
Profit Quality N/A
Current Ratio 4.97
Quick Ratio 4.56
Altman-Z 8.29
F-Score7
WACC9.34%
ROIC/WACC0.03
Cap/Depr(3y)649.08%
Cap/Depr(5y)464.88%
Cap/Sales(3y)15.17%
Cap/Sales(5y)10.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)864691128455134800%
EPS 3YN/A
EPS 5Y3.71%
EPS Q2Q%90%
EPS Next Y24.67%
EPS Next 2Y87.87%
EPS Next 3Y80.79%
EPS Next 5Y49.77%
Revenue 1Y (TTM)16.13%
Revenue growth 3Y14.95%
Revenue growth 5Y15.01%
Sales Q2Q%20.09%
Revenue Next Year15.49%
Revenue Next 2Y18.83%
Revenue Next 3Y20.01%
Revenue Next 5Y22.42%
EBIT growth 1Y131.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2049.78%
EBIT Next 3Y242.31%
EBIT Next 5Y173.2%
FCF growth 1Y-161.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.11%
OCF growth 3Y26.05%
OCF growth 5YN/A